Gorgas Gregory D.

Pres, CEO, CFO, Treas & Sec, DirectorARTELO BIOSCIENCES, INC. (ARTL) · full profile →Form 4 · filed Mar 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2024Disposed to issuer(D)5K0
Feb 28, 2024Disposed to issuer(D)56K0
Feb 28, 2024Disposed to issuer(D)38K0
Feb 28, 2024Disposed to issuer(D)90K0
Feb 28, 2024Grant(A)85K85K
Feb 28, 2024Grant(A)5K5K
Feb 28, 2024Grant(A)56K56K
Feb 28, 2024Grant(A)38K38K
Feb 28, 2024Grant(A)90K90K
Feb 28, 2024Disposed to issuer(D)85K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001640334-24-000332) within minutes of acceptance. Every field above traces to the original document. Verify it directly: